Hyperglycemia and mortality in critically ill children;Hyperglykaemia és mortalitás kritikus állapotú gyermekeknél

Orvosi Hetilap

Volumn 148, Issue 15, 2007, Pages 683-688

  Mikos, Borbála ^a,c   Barkai, László ^b  

^a Borsod Abauj Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c NONE   (Hungary)

Author keywords

Mortality; Sepsis; Stress induced hyperglycemia

Indexed keywords

GLUCOSE; ANTIDIABETIC AGENT; INSULIN;

ARTICLE; CARBOHYDRATE METABOLISM; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEPTICEMIA; VALIDATION STUDY; BLOOD; CRITICAL ILLNESS; FEMALE; HUNGARY; INFANT; INTENSIVE CARE; INTERDISCIPLINARY COMMUNICATION; MALE; METABOLISM; MORTALITY; PRESCHOOL CHILD; SEPSIS;

BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; FEMALE; HUMANS; HUNGARY; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; INTENSIVE CARE UNITS, PEDIATRIC; INTERDISCIPLINARY COMMUNICATION; MALE; RETROSPECTIVE STUDIES; SEPSIS;

EID: 34547460578     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2007.27983     Document Type: Article

References (37)

1. Aarsland, A., Chinkes, D., Wolfe, R. R. és mtsai: Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged. Ann. Surg., 1996, 223, 777-789.
2. 2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke, 1999, 30, 160-170.
3. Bolton, C. F.: Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit. Care Med., 1996, 24, 1408-1416.
4. Capes, S. E., Hunt, D., Malmerg, K. és mtsa: Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet, 2000, 355, 773-778.
5. Carter, E. A.: Insulin resistance in burns and trauma. Nutr. Rev., 1998, 56(1 pt 2), S170-176.
6. Chew, W., Kucharczyk, J., Moseley, M. és mtsai: Hyperglycaemia augments ischemic brain injury: in vivo MR imaging/ spectroscopic study with nicardipine in cats with occluded middle cerebral arteries. AJNR = Am. J. Neuroradiol., 1991, 12, 603-609.
7. Das, U. N.: Current advances in sepsis and septic shock with particular emphasis on the role of insulin. Med. Sci. Monit., 2003, 9, RA 181-192.
8. Das, U. N.: Insulin and the critically ill. Crit. Care, 2002, 6, 262-263.
9. Davi, G., Catalano, I., Averna, M. és mtsai: Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N. Engl. J. Med., 1990, 322, 1769-1774.
10. Delamaire, M., Maugendre, D., Moreno, M. és mtsai: Impaired leukocyte functions in diabetic patients. Diabet. Med., 1997, 14, 29-34.
11. Esmann, V.: The diabetic leukocyte. Enzyme, 1972, 13, 32.
12. Furnary, A. P., Zerr, K. J., Grunkemeier, G. L. és mtsa: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann. Thorac. Surg., 1999, 67, 352-362.
13. Golden, S. J., Peart-Vigilance, C., Kao, W. H. és mtsa: Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care, 1999, 22, 1408-1414.
14. Hansen, T. K., Thiel, S., Wouters, P. J. és mtsai: Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J. Clin. Endocrinol. Metab., 2003, 88, 1082-1088.
15. Hostetter, M. K.: Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes, 1990, 39, 271-275.
16. Hotamisligil, G. S., Spiegelman, B. M.: Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes, 1994, 43, 1271-1278.
17. Jain, S. K., Nagi, D. K., Slavin, B. M. és mtsai: Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control. Diabet. Med., 1993, 10, 27-32.
18. Jeevanandam, M., Young, D. H., Schiller, W. R.: Glucose turnover, oxidation, and indices of recycling in severely traumatized patients. J. Trauma Inj. Infec. Crit. Care, 1990, 30, 582-589.
19. Jeschke, M. G., Einspanier, R., Klein, D. és mtsai: Insulin attenuates the systemic inflammatory response to thermal trauma. Mol. Med., 2002, 8, 443-450.
20. Jeschke, M. G., Klein, D., Herndon, D. N.: Insulin Treatment Improves the Systemic Inflammatory Reaction to Severe Trauma. Ann. Surg., 2004, 239, 553-560.
21. Kang, B. P., Frencher, S., Reddy, V. és mtsai: High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. Am. J. Physiol. Renal Physiol., 2003, 284, F455-F466.
22. Krinsley, J. S.: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin. Proc., 2003, 78, 1471-1478.
23. Lattermann, R., Schricker, T., Wachter, U. és mtsai: Understanding the mechanisms by wich isoflurane modifies the hyperglycemic response to surgery. Anesth. Analg. 2001, 93, 121-127.
24. Leijten, F. S. S., Weerd, de, A. W.: Critical illness polyneuropathy: a review of the literature, definition and pathophysiology. Clin. Neurol. Neurosurg. 1994, 96, 10-19.
25. Leroux, J. P., Marchand, J. C., Hong Tuan, H. R. és mtsa: The influence of insulin on glucose permeability and metabolism of human granulocytes. Eur. J. Biochem., 1975, 58, 367.
26. Lewis, K. S.: Intensive Insulin Therapy for Critically Ill Patients. Ann. Pharmacother., 2004, 38(7), 1243-1251.
27. MacCuish, A. C., Urbaniak, S. J., Campbell, C. J.: Phytohemagglutinin transformation and circulating lymphocyte subpopulation in insulin-dependent diabenc patients. Diabetes, 1974, 23, 708.
28. MacRury, S. M., Gemmell, C. G., Paterson, K. R. és mtsa: Changes in phagocytic function with glycaemic control in diabetic patients. J. Clin. Pathol., 1989, 42, 1143-1147.
29. Malmberg, K., Ryden, L., Efendic, S. és mtsai: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 years. J. Am. Coll. Cardiol., 1995, 26, 57-65.
30. Oliver, M. F., Opie, L. H.: Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet, 1994, 343, 155-158.
31. Osier, F. H. A., Berkley, J. A., Ross, A. és mtsai: Abnormal blood glucose concentrations on admission to a rural Kenyan district hospital: prevalence and outcome. Arch Dis Childhood, 2003, 88, 621-625.
32. Rayfield, E. J., Ault, M. J., Keusch, G. T. és mtsai: Infection and diabetes. Am. J. Med., 1982, 72, 439-450.
33. Sakurai, Y., Aarsland, A., Herndon, D. N. és mtsai: Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann. Surg., 1995, 222, 283-297.
34. Sieber, F. E., Traystman, R. J.: Special issues: glucose and the brain. Crit. Care Med., 1992, 20, 104-114.
35. Srinivasan, V., Spinella, P. C., Drott, H. R. és mtsai: Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr. Crit. Care Med., 2004, 5, 329-336.
36. Berghe, van den, G., Wouters, P., Weekers, F. és mtsai: Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 2001, 345, 1359-1367.
37. Zerr, K. J., Furnary, A. P., Grunkemeier, G. L. és mtsai: Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann. Thorac. Surg., 1997, 63, 352-361.